mRNA therapy is also gaining attention in cardiovascular medicine, with clinical trials underway for treatments such as vascular endothelial growth factor (VEGF) mRNA therapy aimed at promoting myocardial revascularization following myocardial infarction [62]. This evidence concerns the gene VEGFA and myocardial infarction.